Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients

被引:124
作者
Chishima, F
Hayakawa, S
Sugita, K
Kinukawa, N
Aleemuzzaman, S
Nemoto, N
Yamamoto, T
Honda, M
机构
[1] Nihon Univ, Sch Med, Dept Obstet & Gynecol, Itabashi Ku, Tokyo 1738610, Japan
[2] Nihon Univ, Sch Med, Dept Pathol, Itabashi Ku, Tokyo, Japan
[3] Natl Inst Informat Dis, AIDS Res Ctr, Shinjuku Ku, Tokyo 1738610, Japan
关键词
adenomyosis; competitive PCR; cyclooxygenase-2; endometriosis;
D O I
10.1034/j.1600-0897.2002.01101.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
PROBLEM: Human endometrial glands contain the highest levels of cyclooxygenase (COX), although whether it is COX-1 and/or COX-2 has not been previously determined. Overexpression of COX-2 may result in the pathogenesis of endometriosis. METHOD OF STUDY: Tissue sections were obtained from 28 premenopausal women undergoing laparotomy or laparoscopic surgery for benign conditions. Endometrium, ectopic endometriosis tissue and peritoneum were obtained at the time of surgery. Informed consents were obtained from all the patients participating in. this study. Immunohistochemistry was performed on consecutive sections of paraffin-embedded tissue using anti-COX-2 antibody. Expressions of COX-2 mRNA in endometrium, ectopic endometriosis tissue, and peritoneum were quantitavely determined by competitive reverse transcription-polymerase chain reaction (RT-PCR). RESULTS: In the uterus, COX-2 was localized in the endometrial epithelium. Eutopic endometrial Surface epithelium contains more COX-2 than does glandular epithelium. We observed more frequent and denser COX-2 staining in the ectopic endometriosis implants when compared with eutopic endometrium. Level of COX-2 mRNA in endometriosis was increased up to five times that of eutopic endometria. CONCLUSION: Hyper activation of COX-2 with abnormal prostaglandin generation is considered to contribute to the pathophysiology of endometriosis and disease progression.
引用
收藏
页码:50 / 56
页数:7
相关论文
共 31 条
[1]  
BADAWY SZA, 1985, INT J FERTIL, V30, P48
[2]  
Chan G, 1999, CANCER RES, V59, P991
[3]   DETERMINATION OF MENSTRUAL PROSTAGLANDIN LEVELS IN NON-DYSMENORRHEIC AND DYSMENORRHEIC SUBJECTS [J].
CHAN, WY ;
HILL, JC .
PROSTAGLANDINS, 1978, 15 (02) :365-375
[4]  
CHISHIMA F, 2000, J OBSTET GYNAECOL RE, V26, P1141
[5]   PERITONEAL-FLUID THROMBOXANE-B2 AND 6-KETO-PROSTAGLANDIN-F1-ALPHA IN ENDOMETRIOSIS [J].
DRAKE, TS ;
OBRIEN, WF ;
RAMWELL, PW ;
METZ, SA .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1981, 140 (04) :401-404
[6]   Decrease in peripheral blood polymorphonuclear leukocyte chemotactic index in endometriosis:: Role of prostaglandin E2 release [J].
Garzetti, GG ;
Ciavattini, A ;
Provinciali, M ;
Amati, M ;
Muzzioli, M ;
Governa, M .
OBSTETRICS AND GYNECOLOGY, 1998, 91 (01) :25-29
[7]  
GLEICHER N, 1994, ACTA OBSTET GYN SCAN, V73, P15
[8]  
HABIB A, 1995, THROMB HAEMOSTASIS, V74, P770
[9]   PERITONEAL-MACROPHAGES FROM PATIENTS WITH ENDOMETRIOSIS RELEASE GROWTH-FACTOR ACTIVITY INVITRO [J].
HALME, J ;
WHITE, C ;
KAUMA, S ;
ESTES, J ;
HASKILL, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 66 (05) :1044-1049
[10]   ALTERED MATURATION AND FUNCTION OF PERITONEAL-MACROPHAGES - POSSIBLE ROLE IN PATHOGENESIS OF ENDOMETRIOSIS [J].
HALME, J ;
BECKER, S ;
HASKILL, S .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1987, 156 (04) :783-789